226 related articles for article (PubMed ID: 25964595)
21. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis.
Clarke JW; Register S; McGregor JM; Grecula JC; Mayr NA; Wang JZ; Li K; Gupta N; Kendra KL; Olencki TE; Cavaliere R; Sarkar A; Lo SS
Am J Clin Oncol; 2010 Feb; 33(1):70-4. PubMed ID: 19652578
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases.
Tsao M; Xu W; Sahgal A
Cancer; 2012 May; 118(9):2486-93. PubMed ID: 21887683
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.
Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R
J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795
[TBL] [Abstract][Full Text] [Related]
24. Fractionated stereotactic radiotherapy for small-cell lung cancer patients with brain metastases.
Li XP; Xiao JP; Chen XJ; Jiang XS; Zhang Y; Xu YJ
J Cancer Res Ther; 2014; 10(3):597-602. PubMed ID: 25313746
[TBL] [Abstract][Full Text] [Related]
25. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
[TBL] [Abstract][Full Text] [Related]
26. Treatment of five or more brain metastases with stereotactic radiosurgery.
Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
[TBL] [Abstract][Full Text] [Related]
27. Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection.
Kurtz G; Zadeh G; Gingras-Hill G; Millar BA; Laperriere NJ; Bernstein M; Jiang H; Ménard C; Chung C
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):137-42. PubMed ID: 24331660
[TBL] [Abstract][Full Text] [Related]
28. Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery.
Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J
Strahlenther Onkol; 2004 Sep; 180(9):590-6. PubMed ID: 15378190
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2020; 10():693. PubMed ID: 32477942
[No Abstract] [Full Text] [Related]
30. Comparison of different treatment approaches for one to two brain metastases in elderly patients.
Rades D; Pluemer A; Veninga T; Schild SE
Strahlenther Onkol; 2008 Nov; 184(11):565-71. PubMed ID: 19016014
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic radiotherapy for patients who initially presented with brain metastases from non-small cell carcinoma.
Nakayama H; Tokuuye K; Komatsu Y; Ishikawa H; Shiotani S; Nakada Y; Akine Y
Acta Oncol; 2004; 43(8):736-9. PubMed ID: 15764218
[TBL] [Abstract][Full Text] [Related]
32. Reirradiation of brain metastases with radiosurgery.
Maranzano E; Trippa F; Casale M; Costantini S; Anselmo P; Carletti S; Principi M; Caserta C; Loreti F; Giorgi C
Radiother Oncol; 2012 Feb; 102(2):192-7. PubMed ID: 21880387
[TBL] [Abstract][Full Text] [Related]
33. Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma.
Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
Anticancer Res; 2018 May; 38(5):2973-2976. PubMed ID: 29715126
[TBL] [Abstract][Full Text] [Related]
34. Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis.
D'Agostino GR; Autorino R; Pompucci A; De Santis MC; Manfrida S; Di Lella G; Mantini G; Frascino V; Chiesa S; Albanese A; Dinapoli N; Azario L; Fiorentino A; Valentini V; Anile C; Balducci M
Strahlenther Onkol; 2011 Jul; 187(7):421-5. PubMed ID: 21713390
[TBL] [Abstract][Full Text] [Related]
35. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
[TBL] [Abstract][Full Text] [Related]
36. The clinical results of pediatric brain tumors treated with Linac-based stereotactic radiosurgery and radiotherapy.
Puataweepong P; Dhanachai M; Dangprasert S; Narkwong L; Sitathanee C; Junwityanujit T
J Med Assoc Thai; 2012 Nov; 95(11):1466-71. PubMed ID: 23252214
[TBL] [Abstract][Full Text] [Related]
37. Single dose versus fractionated stereotactic radiotherapy for meningiomas.
Lo SS; Cho KH; Hall WA; Kossow RJ; Hernandez WL; McCollow KK; Gerbi BJ; Higgins PD; Lee CK; Dusenbery KE
Can J Neurol Sci; 2002 Aug; 29(3):240-8. PubMed ID: 12195613
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic radiotherapy for large solitary brain metastases.
Feuvret L; Vinchon S; Martin V; Lamproglou I; Halley A; Calugaru V; Chea M; Valéry CA; Simon JM; Mazeron JJ
Cancer Radiother; 2014 Mar; 18(2):97-106. PubMed ID: 24439342
[TBL] [Abstract][Full Text] [Related]
39. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases.
Lindvall P; Bergström P; Löfroth PO; Henriksson R; Bergenheim AT
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1460-6. PubMed ID: 15817351
[TBL] [Abstract][Full Text] [Related]
40. Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases.
Sim AJ; Ahmed KA; Keller A; Figura NB; Oliver DE; Sarangkasiri S; Robinson TJ; Johnstone PAS; Yu HM; Naghavi AO
Am J Clin Oncol; 2020 May; 43(5):356-361. PubMed ID: 32217854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
